Scientists study rare Ebola strain in DR Congo after 5,500 deaths
By Health Desk
Medical experts are studying a rare Ebola outbreak in the Democratic Republic of Congo that has resulted in over 5,500 deaths. Researchers are testing new vaccines and treatments to combat the virus, which is spreading at double the pace of previous major outbreaks.
Scientists and medical professionals are working to gain a deeper understanding of a rare Ebola outbreak in the Democratic Republic of Congo. The ongoing crisis, which involves the Bundibugyo strain of the virus, has resulted in more than 11,000 cases and over 5,500 deaths since it was officially declared in May.
The current outbreak is spreading at double the pace of the 2014 to 2016 Ebola crisis in West Africa, which remains the largest on record. Experts from the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) believe that transmission may have been occurring for months before the official declaration. The region, located in eastern Congo, is also currently facing a wider humanitarian crisis, which officials say complicates data collection and the overall response.
A primary challenge for health workers is the nature of the symptoms associated with this strain. According to Yap Boum, Africa CDC's deputy Ebola incident manager, bleeding occurs in only 5% to 10% of confirmed cases. This makes the virus easier to confuse with other prevalent illnesses such as malaria, which contributed to initial difficulties in detection. Furthermore, standard tests designed for other Ebola species do not identify the Bundibugyo strain, further hindering early identification.
The impact on children is particularly severe. Data from the Congolese Ministry of Health and the WHO indicates there have been 1,207 confirmed cases in children under the age of five, with 844 deaths. Catherine Smallwood, the WHO’s Ebola incident manager, noted that gastrointestinal symptoms are more common than fever in young children, which can hinder early diagnosis and treatment. In contrast, the fatality rate among adults in this outbreak is approximately 50%.
Efforts to manage the outbreak are hampered by the fact that roughly 70% of patients die within their communities rather than in healthcare facilities. Sylvie Jonckheere of Medecins Sans Frontieres stated that the high number of unidentified cases makes it difficult to track the virus or identify patients with milder symptoms. Despite these hurdles, genomic sequencing suggests the virus is not mutating rapidly or becoming more transmissible.
Researchers are now focusing on potential medical interventions. A trial of Merck’s Ervebo vaccine is currently assessing whether it provides cross-protection against the Bundibugyo strain. Additionally, medics are testing prophylactic antivirals and treatments developed by Gilead Sciences and Mapp Biopharmaceutical. While there are currently no licensed vaccines or treatments for this specific strain, experts believe that proving the efficacy of available options could significantly alter the course of the outbreak.
Daniel Bausch, a member of the WHO’s Ebola emergency committee and a visiting professor at the Geneva Graduate Institute, emphasised the difficulty of comparing data across different outbreaks. He noted that while bleeding was once considered a hallmark of Ebola, it appears less common in this specific strain. Jean-Jacques Muyembe, co-discoverer of Ebola and head of Congo’s National Institute for Biomedical Research, added that bleeding for some patients is occurring later in the disease progression.
The WHO has noted that around 700 survivors have enrolled in study and support schemes to better understand the long-term implications of the infection. Experts remain cautious, noting that while standard control measures such as patient isolation have proven effective in some early hot spots, the lack of licensed treatments remains a critical barrier. The virus appears to transmit only when patients are symptomatic, providing a window for intervention if cases can be identified early enough.
Elected News
-
Bangladesh Seeks UN Women Support on Digital Harassment and Women’s Empowerment
-
Bangladesh, Australia Discuss Human Trafficking, Irregular Migration and Rohingya Crisis
-
Bangladesh Plans Internet-Free Access to Mobile Banking and Financial Apps
-
DU to Open Undergraduate Admission Applications on 11 November, Tests Begin 5 December